Prohivitac

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameProhivitac

Drug Alias NameHIV vaccine (Hollis-Eden)

ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHarbor Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHarbor Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A